Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers

By afschroeder • February 2, 2026

Riemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud A, Clarke D, Moore A, Hardin ME, Holweg CTJ, Allu S, Hinks TSC, Beasley RW, Sont JK, Steyerberg EW, Pavord ID, Brusselle G, Couillard S. Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers. Chest. 2026 Jan 30:S0012-3692(26)00131-5. doi: 10.1016/j.chest.2025.12.049. Epub ahead of print. PMID: 41621639.

Tags: Allergy & Immunology, asthma, biomarkers, blood eosinophils, exacerbation, FeNO, General Internal Medicine, LIST, meta-analysis, Publications

FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma

Corren J, Reid F, Moate R, Jimenez E, Sadiq MW, Williams A, Rytelewski M, Cameron-Christie S, Muthas D, Georgi B, Brooks D, Lindqvist E, Kell[...]

UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetes

Chen HC, Bang MF, Wang HH, Shpargel KB, Kohn LA, Sailer D, Zhang S, McCarthy EC, Seyedsadr M, Stevens S, Pham CLH, Zhou Z, Yin[...]

The Possible Unveiling of Myasthenia Gravis via Allergy Shots

Thakor Philipp A, Anderson L. The Possible Unveiling of Myasthenia Gravis via Allergy Shots. Cureus. 2025 Sep 9;17(9):e91927. doi: 10.7759/cureus.91927. PMID: 41080268; PMCID: PMC12510673.